Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 5, 2013, Pages 487-495

  Gelman, Benjamin B ^a   Lisinicchia, Joshua G ^a   Morgello, Susan ^b   Masliah, Eliezer ^c   Commins, Deborah ^d   Achim, Cristian L ^c   Fox, Howard S ^e   Kolson, Dennis L ^f   Grant, Igor ^c   Singer, Elyse ^g   Yiannoutsos, Constantin T ^h   Sherman, Seth ⁱ   Gensler, Gary ⁱ   Moore, David J ^c   Chen, Tiansheng ^a   Soukup, Vicki M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ EMMES CORPORATION   (United States)

Author keywords

Dementia; Encephalitis; HAND; HIVE; Interferon; Neurocognitive disorders

Indexed keywords

DNA; RNA; VIRUS RNA;

ADULT; ARTICLE; BRAIN; CEREBROSPINAL FLUID; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; HIV ASSOCIATED DEMENTIA; HIV ENCEPHALITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROGLIAL NODULE ENCEPHALITIS; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; VIRUS LOAD;

ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN; COGNITION DISORDERS; COHORT STUDIES; DNA, VIRAL; ENCEPHALITIS; FEMALE; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; STATISTICS, NONPARAMETRIC;

EID: 84876409055     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827f1bdb     Document Type: Article

References (40)

1. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75:2087-2096.
2. McArthur JC, Steiner J, Sacktor N, et al. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol. 2010;67:699-714.
3. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-1799.
4. Achim CL, Wang R, Miners DK, et al. Brain viral burden in HIV infection. J Neuropathol Exp Neurol. 1994;53:284-294.
5. Wiley CA, Soontornniyomkij V, RadhakrishnanL, et al. Distribution of brain HIV load in AIDS. Brain Pathol. 1998;8:277-284.
6. Gendelman HE, Lipton SA, Tardieu M, et al. The neuropathogenesis of HIV-1 infection. J Leukoc Biol. 1994;56:389-398.
7. Williams KC, Hickey WF. Central nervous system damage, monocyte and macrophages and neurological disorders in AIDS. Ann Rev Neurosci. 2002;25:537-562.
8. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410:988-994.
9. Glass JD, Fedor H, Wesselingh SL, et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995;38:755-762.
10. Glass JD, Wesselingh SL, Selnes OA, et al. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology. 1993;43:2230-2237.
11. Wiley CA, Achim CL. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 1994;36:673-676.
12. Anthony IC, Bell JE. The neuropathology of HIV/AIDS. Int Rev Psychiatry. 2008;20:15-24.
13. Everall I, Vaida F, Khanlou N, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol. 2009;15:360-370.
14. Gelman BB, Moore DH. HIV-1 neuropathology. In: Gendelman HE, Fox HS, Lipton SA, et al, eds. Neurology of AIDS. 3rd ed. New York: Oxford University Press, 2012;518-535.
15. Morgello S, Gelman BB, Kozlowski P, et al. The national neuroAIDS tissue consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol. 2001;27:326-335.
16. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26:759-778.
17. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778-785.
18. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathologybased terminology. Brain Pathol. 1991;1:143-152.
19. Palmer S, Wiegand AP, Maldarelli F, et al. New real-time reverse transcriptase- initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41:4531-4536.
20. Gelman BB, Lisinicchia JG, Chen T, et al. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol. 2012;8:1-15.
21. Morgello S, Holzer CE 3rd, Ryan E, et al. Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res. 2006;15:131-138.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995; 57:289-300.
23. Masliah E, Roberts ES, Langford D, et al. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol. 2004;157:163-175.
24. Sas AR, Bimonte-Nelson H, Smothers CT, et al. Interferon-a causes neuronal dysfunction in encephalitis. J Neurosci. 2009;29:3948-3955.
25. Horiuchi M, Itoh A, Pleasure D, et al. Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-g-mediated cytotoxic effects on oligodendroglial progenitor cells. J Neuroinflamm. 2011;8:8. doi:10.1186/1742-2094-8-8.
26. Masliah E, DeTeresa RM, Mallory ME, et al. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS. 2000;14:69-74.
27. Morgello SM, Mahboob R, Yakoushina T, et al. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades. Influence of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med. 2002;126:182-190.
28. Gelman BB, Soukup VM, Keherly MJ, et al. Acquired neuronal channelopathies in HIV-associated dementia. J Neuroimmunol. 2004;157:111-119.
29. Ellis R, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol. 1997;42:679-688.
30. McArthur JC, McDermott MP, McClernon D, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol. 2004;61:1687-1696.
31. Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE. 2008;3:e2516. doi:10.1371/journal.pone.0002516.
32. Gartner S. HIV infection and dementia. Science. 2000;287:602-604.
33. Lyons JL, Uno H, Ancuta P, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011;57:371-379.
34. Fox HS, Gold LH, Henriksen SJ, et al. Simian immunodeficiency virus: a model for NeuroAIDS. Neurobiol Dis. 1997;4:265-274.
35. Gelman BB. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol. 1993;34:65-70.
36. Bell JE, Brettel RP, Chiswick A, et al. HIV encephalitis, proviral load, and dementia in drug users and homosexuals with AIDS: effect of neocortical involvement. Brain. 1998;121:2043-2052.
37. Xing HQ, Hayakawa H, Gelpi E, et al. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J Neuropathol Exp Neurol. 2009;68:199-209.
38. Nebuloni M, Pellegrinelli A, Ferri A, et al. Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J Neurovirol. 2000;6:46-50.
39. Bell JE, Arango JC, Robertson R, et al. HIV and drug misuse in the Edinburgh cohort. J Acquir Immune Defic Syndr. 2002;31(suppl 2):S35-S42.
40. Buttini M, Limonta S, Boddeke HW. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem Int. 1996;29:25-35.